A Pilot RCT of Veraflo With Prontosan vs VAC in Wounds Requiring Operative Debridement

NCT01867580 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 181

Last updated 2024-12-02

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to examine the effectiveness of the Veraflo with Prontosan vs VAC in wounds that require operative debridement.

Conditions

  • Wounds and Injuries

Interventions

DEVICE

V.A.C.Ulta with Prontosan instillation

NPWT with instillation of a wound cleanser (Prontosan® Wound Irrigation Solution)

DEVICE

V.A.C.Ulta without instillation

NPWT only

Sponsors & Collaborators

  • KCI USA, Inc

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2015-08-31
Completion
2015-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01867580 on ClinicalTrials.gov